Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Whole-body magnetic resonance imaging (WB-MRI) as surveillance for subsequent malignancies in survivors of hereditary retinoblastoma: a pilot study.

Friedman DN, Lis E, Sklar CA, Oeffinger KC, Reppucci M, Fleischut MH, Francis JH, Marr B, Abramson DH, Dunkel IJ.

Pediatr Blood Cancer. 2014 Aug;61(8):1440-4. doi: 10.1002/pbc.24835. Epub 2013 Nov 1.

2.

Risk of subsequent malignant neoplasms in long-term hereditary retinoblastoma survivors after chemotherapy and radiotherapy.

Wong JR, Morton LM, Tucker MA, Abramson DH, Seddon JM, Sampson JN, Kleinerman RA.

J Clin Oncol. 2014 Oct 10;32(29):3284-90. doi: 10.1200/JCO.2013.54.7844. Epub 2014 Sep 2.

3.

Second malignant neoplasms following chemoreduction with carboplatin, etoposide, and vincristine in 245 patients with intraocular retinoblastoma.

Turaka K, Shields CL, Meadows AT, Leahey A.

Pediatr Blood Cancer. 2012 Jul 15;59(1):121-5. doi: 10.1002/pbc.23278. Epub 2011 Aug 8.

PMID:
21826785
4.

Second cranio-facial malignancies in hereditary retinoblastoma survivors previously treated with radiation therapy: clinic and radiologic characteristics and survival outcomes.

Rodjan F, Graaf Pd, Brisse HJ, Verbeke JI, Sanchez E, Galluzzi P, Göricke S, Maeder P, Aerts I, Dendale R, Desjardins L, de Franscesco S, Bornfeld N, Sauerwein W, Popovic MB, Knol DL, Moll AC, Castelijns JA.

Eur J Cancer. 2013 May;49(8):1939-47. doi: 10.1016/j.ejca.2013.01.010. Epub 2013 Feb 14.

5.

Long-term medical outcomes in survivors of extra-ocular retinoblastoma: the Memorial Sloan-Kettering Cancer Center (MSKCC) experience.

Friedman DN, Sklar CA, Oeffinger KC, Kernan NA, Khakoo Y, Marr BP, Wolden SL, Abramson DH, Dunkel IJ.

Pediatr Blood Cancer. 2013 Apr;60(4):694-9. doi: 10.1002/pbc.24280. Epub 2012 Aug 21.

PMID:
22911631
6.

Secondary malignant neoplasms among children, adolescents, and young adults with osteosarcoma.

Lee JS, DuBois SG, Boscardin WJ, Wustrack RL, Goldsby RE.

Cancer. 2014 Dec 15;120(24):3987-93. doi: 10.1002/cncr.28936. Epub 2014 Aug 12.

7.

Chronic medical conditions in adult survivors of retinoblastoma: Results of the Retinoblastoma Survivor Study.

Friedman DN, Chou JF, Oeffinger KC, Kleinerman RA, Ford JS, Sklar CA, Li Y, McCabe MS, Robison LL, Marr BP, Abramson DH, Dunkel IJ.

Cancer. 2016 Mar 1;122(5):773-81. doi: 10.1002/cncr.29704. Epub 2016 Jan 11.

PMID:
26755259
8.

CT and MRI features of recurrent tumors and second primary neoplasms in pediatric patients with retinoblastoma.

Tateishi U, Hasegawa T, Miyakawa K, Sumi M, Moriyama N.

AJR Am J Roentgenol. 2003 Sep;181(3):879-84.

PMID:
12933497
9.

Aggressive management of second primary tumors in survivors of hereditary retinoblastoma.

Smith LM, Donaldson SS, Egbert PR, Link MP, Bagshaw MA.

Int J Radiat Oncol Biol Phys. 1989 Sep;17(3):499-505.

PMID:
2777644
10.

Whole-body MRI of paediatric malignant tumours: comparison with conventional oncological imaging methods.

Goo HW, Choi SH, Ghim T, Moon HN, Seo JJ.

Pediatr Radiol. 2005 Aug;35(8):766-73. Epub 2005 Apr 28.

PMID:
15864576
11.

Risk of second malignancies in survivors of retinoblastoma: more than 40 years of follow-up.

Marees T, Moll AC, Imhof SM, de Boer MR, Ringens PJ, van Leeuwen FE.

J Natl Cancer Inst. 2008 Dec 17;100(24):1771-9. doi: 10.1093/jnci/djn394. Epub 2008 Dec 9.

12.

Baseline central nervous system magnetic resonance imaging in early detection of trilateral retinoblastoma: pitfalls in the diagnosis of pineal gland lesions.

De Ioris MA, Valente P, Randisi F, Buzzonetti L, Carai A, Cozza R, Del Bufalo F, Romanzo A, Angioni A, Cacchione A, Bernardi B, Mastronuzzi A.

Anticancer Res. 2014 Dec;34(12):7449-54.

PMID:
25503186
13.

Cancer mortality in long-term survivors of retinoblastoma.

Marees T, van Leeuwen FE, de Boer MR, Imhof SM, Ringens PJ, Moll AC.

Eur J Cancer. 2009 Dec;45(18):3245-53. doi: 10.1016/j.ejca.2009.05.011. Epub 2009 Jun 1.

PMID:
19493675
14.

Whole-body magnetic resonance imaging and positron emission tomography-computed tomography in oncology.

Schmidt GP, Kramer H, Reiser MF, Glaser C.

Top Magn Reson Imaging. 2007 Jun;18(3):193-202. Review.

PMID:
17762383
15.

Ewing's sarcoma as second malignant neoplasm after retinoblastoma: a case report.

Mittal R, Al Awadi S, Sahar O, Behbehani AM.

Med Princ Pract. 2008;17(1):84-5.

PMID:
18059108
16.

Cancer screening practices of adult survivors of retinoblastoma at risk of second cancers.

Sheen V, Tucker MA, Abramson DH, Seddon JM, Kleinerman RA.

Cancer. 2008 Jul 15;113(2):434-41. doi: 10.1002/cncr.23564.

17.

Second malignant neoplasms in children with retinoblastoma: the St. Jude Children's Research Hospital experience.

Fontanesi J, Parham DM, Pratt C, Meyer D.

Ophthalmic Genet. 1995 Sep;16(3):105-8.

PMID:
8556278
18.

High-resolution whole-body magnetic resonance image tumor staging with the use of parallel imaging versus dual-modality positron emission tomography-computed tomography: experience on a 32-channel system.

Schmidt GP, Baur-Melnyk A, Herzog P, Schmid R, Tiling R, Schmidt M, Reiser MF, Schoenberg SO.

Invest Radiol. 2005 Dec;40(12):743-53.

PMID:
16304476
19.

Risk of new cancers after radiotherapy in long-term survivors of retinoblastoma: an extended follow-up.

Kleinerman RA, Tucker MA, Tarone RE, Abramson DH, Seddon JM, Stovall M, Li FP, Fraumeni JF Jr.

J Clin Oncol. 2005 Apr 1;23(10):2272-9.

20.

Mortality from second tumour among long-term survivors of retinoblastoma: a retrospective analysis of the Italian retinoblastoma registry.

Acquaviva A, Ciccolallo L, Rondelli R, Balistreri A, Ancarola R, Cozza R, Hadjistilianou D, Francesco SD, Toti P, Pastore G, Haupt R, Carli M, Santoro N, Di Cataldo A, Fiorillo A, Indolfi P, Nucci P, Sandri A, Porta F, Porcaro AB, Tamaro P, Morgese G.

Oncogene. 2006 Aug 28;25(38):5350-7.

PMID:
16936757
Items per page

Supplemental Content

Write to the Help Desk